Is Your LC Column for Biologics Analysis, Truly Bio-Inert?

Let’s talk about column priming and how to address this common concern Guest Author: Chad Eichman, Ph.D., Biopharmaceutical Industry Manager With the emerging trend of biotherapeutics in the pharmaceutical industry, Continue Reading

ADCs-Magic Bullets, Failed Drugs, and Heterobifunctional Linkers

ADCs

Guest Author: Brian Rivera, Product Manager: Bio Separations Over a hundred years ago, Nobel Prize laureate, Paul Ehrlich, envisioned a drug which could kill microbes but not harm the body, Continue Reading